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Abstract
In this paper, we propose a new method remMap — REgularized Multi-
variate regression for identifying MAster Predictors — for fitting multivariate
response regression models under the high-dimension-low-sample-size setting.
remMap is motivated by investigating the regulatory relationships among differ-
ent biological molecules based on multiple types of high dimensional genomic
data. Particularly, we are interested in studying the influence of DNA copy
number alterations on RNA transcript levels. For this purpose, we model the
dependence of the RNA expression levels on DNA copy numbers through multi-
variate linear regressions and utilize proper regularization to deal with the high
dimensionality as well as to incorporate desired network structures. Criteria
for selecting the tuning parameters are also discussed. The performance of the
proposed method is illustrated through extensive simulation studies. Finally,
remMap is applied to a breast cancer study, in which genome wide RNA tran-
script levels and DNA copy numbers were measured for 172 tumor samples. We
identify a trans-hub region in cytoband 17q12-q21, whose amplification influ-
ences the RNA expression levels of more than 30 unlinked genes. These findings
may lead to a better understanding of breast cancer pathology.
Key words: sparse regression, MAP(MAster Predictor) penalty, DNA copy num-
ber alteration, RNA transcript level, v-fold cross validation.
1 Introduction
In a few recent breast cancer cohort studies, microarray expression experiments
and array CGH (comparative genomic hybridization) experiments have been con-
ducted for more than 170 primary breast tumor specimens collected at multiple can-
cer centers (Sorlie et al. 2001; Sorlie et al. 2003; Zhao et al. 2004; Kapp et al. 2006;
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Bergamaschi et al. 2006; Langerod et al. 2007; Bergamaschi et al. 2008). The re-
sulting RNA transcript levels (from microarray expression experiments) and DNA
copy numbers (from CGH experiments) of about 20K genes/clones across all the tu-
mor samples were then used to identify useful molecular markers for potential clinical
usage. While useful information has been revealed by analyzing expression arrays
alone or CGH arrays alone, careful integrative analysis of DNA copy numbers and
expression data are necessary as these two types of data provide complimentary in-
formation in gene characterization. Specifically, RNA data give information on genes
that are over/under-expressed, but do not distinguish primary changes driving can-
cer from secondary changes resulting from cancer, such as proliferation rates and
differentiation state. On the other hand, DNA data give information on gains and
losses that are drivers of cancer. Therefore, integrating DNA and RNA data helps
to discern more subtle (yet biologically important) genetic regulatory relationships in
cancer cells (Pollack et al. 2002).
It is widely agreed that variations in gene copy numbers play an important
role in cancer development through altering the expression levels of cancer-related
genes (Albertson et al. 2003). This is clear for cis-regulations, in which a gene’s DNA
copy number alteration influences its own RNA transcript level (Hyman et al. 2002;
Pollack et al. 2002). However, DNA copy number alterations can also alter in trans
the RNA transcript levels of genes from unlinked regions, for example by directly al-
tering the copy number and expression of transcriptional regulators, or by indirectly
altering the expression or activity of transcriptional regulators, or through genome re-
arrangements affecting cis-regulatory elements. The functional consequences of such
trans-regulations are much harder to establish, as such inquiries involve assessment of
a large number of potential regulatory relationships. Therefore, to refine our under-
standing of how these genome events exert their effects, we need new analytical tools
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that can reveal the subtle and complicated interactions among DNA copy numbers
and RNA transcript levels. Knowledge resulting from such analysis will help shed
light on cancer mechanisms.
The most straightforward way to model the dependence of RNA levels on DNA
copy numbers is through a multivariate response linear regression model with the
RNA levels being responses and the DNA copy numbers being predictors. While the
multivariate linear regression is well studied in statistical literature, the current prob-
lem bears new challenges due to (i) high-dimensionality in terms of both predictors
and responses; (ii) the interest in identifying master regulators in genetic regulatory
networks; and (iii) the complicated relationships among response variables. Thus, the
naive approach of regressing each response onto the predictors separately is unlikely to
produce satisfactory results, as such methods often lead to high variability and over-
fitting. This has been observed by many authors, for example, Breiman et al. (1997)
show that taking into account of the relation among response variables helps to im-
prove the overall prediction accuracy. More recently, Kim et al. (2008) propose a
new statistical framework to explicitly incorporate the relationships among responses
by assuming the linked responses depend on the predictors in a similar way. The
authors show that this approach helps to select relevant predictors when the above
assumption holds.
When the number of predictors is moderate or large, model selection is often
needed for prediction accuracy and/or model interpretation. Standard model selection
tools in multiple regression such as AIC and forward stepwise selection have been ex-
tended to multivariate linear regression models (Bedrick et al. 1994; Fujikoshi et al. 1997;
Lutz and Bu¨hlmann 2006). More recently, sparse regularization schemes have been
utilized for model selection under the high dimensional multivariate regression setting.
For example, Turlach et al. (2005) propose to constrain the coefficient matrix of a
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multivariate regression model to lie within a suitable polyhedral region. Lutz and Bu¨hlmann (2006)
propose an L2 multivariate boosting procedure. Obozinskiy et al. (2008) propose to
use a ℓ1/ℓ2 regularization to identify the union support set in the multivariate regres-
sion. Moreover, Brown et al. (1998, 1999, 2002) introduce a Bayesian framework to
model the relation among the response variables when performing variable selection
for multivariate regression. Another way to reduce the dimensionality is through fac-
tor analysis. Related work includes Izenman (1975), Frank et al. (1993), Reinsel and Velu (1998), Yuan et al. (2007)
and many others.
For the problem we are interested in here, the dimensions of both predictors and
responses are large (compared to the sample size). Thus in addition to assuming
that only a subset of predictors enter the model, it is also reasonable to assume
that a predictor may affect only some but not all responses. Moreover, in many
real applications, there often exist a subset of predictors which are more impor-
tant than other predictors in terms of model building and/or scientific interest. For
example, it is widely believed that genetic regulatory relationships are intrinsically
sparse (Jeong et al. 2001; Gardner et al. 2003). At the same time, there exist master
regulators — network components that affect many other components, which play im-
portant roles in shaping the network functionality. Most methods mentioned above do
not take into account the dimensionality of the responses, and thus a predictor/factor
influences either all or none responses, e.g., Turlach et al. (2005), Yuan et al. (2007),
the L2 row boosting by Lutz and Bu¨hlmann (2006), and the ℓ1/ℓ2 regularization by
Obozinskiy et al. (2008). On the other hand, other methods only impose a sparse
model, but do not aim at selecting a subset of predictors, e.g., the L2 boosting by
Lutz and Bu¨hlmann (2006). In this paper, we propose a novel method remMap —
REgularized Multivariate regression for identifying MAster Predictors, which takes
into account both aspects. remMap uses an ℓ1 norm penalty to control the over-
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all sparsity of the coefficient matrix of the multivariate linear regression model. In
addition, remMap imposes a “group” sparse penalty, which in essence is the same
as the “group lasso” penalty proposed by Bakin (1999), Antoniadis and Fan (2001),
Yuan and Lin (2006), Zhao et al. (2006) and Obozinskiy et al. (2008) (see more dis-
cussions in Section 2). This penalty puts a constraint on the ℓ2 norm of regression
coefficients for each predictor, which controls the total number of predictors entering
the model, and consequently facilitates the detection of master predictors. The per-
formance of the proposed method is illustrated through extensive simulation studies.
We apply the remMap method on the breast cancer data set mentioned earlier and
identify a significant trans-hub region in cytoband 17q12-q21, whose amplification
influences the RNA levels of more than 30 unlinked genes. These findings may shed
some light on breast cancer pathology. We also want to point out that analyzing
CGH arrays and expression arrays together reveals only a small portion of the regu-
latory relationships among genes. However, it should identify many of the important
relationships, i.e., those reflecting primary genetic alterations that drive cancer de-
velopment and progression. While there are other mechanisms to alter the expression
of master regulators, for example by DNA mutation or methylation, in most cases
one should also find corresponding DNA copy number changes in at least a subset
of cancer cases. Nevertheless, because we only identify the subset explainable by
copy number alterations, the words “regulatory network” (“master regulator”) used
in this paper will specifically refer to the subnetwork (hubs of the subnetwork) whose
functions change with DNA copy number alterations, and thus can be detected by
analyzing CGH arrays together with expression arrays.
The rest of the paper is organized as follows. In Section 2, we describe the remMap
model, its implementation and criteria for tuning. In Section 3, the performance of
remMap is examined through extensive simulation studies. In Section 4, we apply the
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remMap method on the breast cancer data set. We conclude the paper with discussions
in Section 5. Technical details are provided in the supplementary material.
2 Method
2.1 Model
Consider multivariate regression with Q response variables y1, · · · , yQ and P predic-
tion variables x1, · · · , xP :
yq =
P∑
p=1
xpβpq + ǫq, q = 1, · · · , Q, (1)
where the error terms ǫ1, · · · , ǫQ have a joint distribution with mean 0 and covariance
Σǫ. The primary goal of this paper is to identify non-zero entries in the P × Q
coefficient matrix B = (βpq) based on N i.i.d samples from the above model. Under
normality assumptions, βpq can be interpreted as proportional to the conditional
correlation Cor(yq, xp|x−(p)), where x−(p) := {xp′ : 1 ≤ p
′ 6= p ≤ P}. In the following,
we use Yq = (y
1
q , · · · , y
N
q )
T and Xp = (x
1
p, · · · , x
N
p )
T to denote the sample of the qth
response variable and that of the pth prediction variable, respectively. We also use
Y = (Y1 : · · · : YQ) to denote the N×Q response matrix, and use X = (X1 : · · · : XP )
to denote the N × P prediction matrix.
In this paper, we shall focus on the cases where both Q and P are larger than
the sample size N . For example, in the breast cancer study discussed in Section 4,
the sample size is 172, while the number of genes and the number of chromosomal
regions are on the order of a couple of hundreds (after pre-screening). When P > N ,
the ordinary least square solution is not unique, and regularization becomes indis-
pensable. The choice of suitable regularization depends heavily on the type of data
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structure we envision. In recent years, ℓ1-norm based sparsity constraints such as lasso
(Tibshirani 1996) have been widely used under such high-dimension-low-sample-size
settings. This kind of regularization is particularly suitable for the study of genetic
pathways, since genetic regulatory relationships are widely believed to be intrinsically
sparse (Jeong et al. 2001; Gardner et al. 2003). In this paper, we impose an ℓ1 norm
penalty on the coefficient matrix B to control the overall sparsity of the multivariate
regression model. In addition, we put constraints on the total number of predictors
entering the model. This is achieved by treating the coefficients corresponding to
the same predictor (one row of B) as a group, and then penalizing their ℓ2 norm. A
predictor will not be selected into the model if the corresponding ℓ2 norm is shrunken
to 0. Thus this penalty facilitates the identification of master predictors — predic-
tors which affect (relatively) many response variables. This idea is motivated by the
fact that master regulators exist and are of great interest in the study of many real
life networks including genetic regulatory networks. Specifically, for model (1), we
propose the following criterion
L(B;λ1, λ2) =
1
2
||Y −
P∑
p=1
XpBp||
2
F + λ1
P∑
p=1
||Cp · Bp||1 + λ2
P∑
p=1
||Cp ·Bp||2, (2)
where Cp is the pth row of C = (cpq) = (C
T
1 : · · · : C
T
P )
T , which is a pre-specified
P ×Q 0-1 matrix indicating the coefficients on which penalization is imposed; Bp is
the pth row of B; || · ||F denotes the Frobenius norm of matrices; || · ||1 and || · ||2 are
the ℓ1 and ℓ2 norms for vectors, respectively; and “·” stands for Hadamard product
(that is, entry-wise multiplication). The indicator matrix C is pre-specified based on
prior knowledge: if we know in advance that predictor xp affects response yq, then
the corresponding regression coefficient βpq will not be penalized and we set cpq = 0
(see Section 4 for an example). When there is no such prior information, C can be
simply set to a constant matrix cpq ≡ 1. Finally, an estimate of the coefficient matrix
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B is B̂(λ1, λ2) := argminB L(B;λ1, λ2).
In the above criterion function, the ℓ1 penalty induces the overall sparsity of
the coefficient matrix B. The ℓ2 penalty on the row vectors Cp · Bp induces row
sparsity of the product matrix C · B. As a result, some rows are shrunken to be
entirely zero (Theorem 1). Consequently, predictors which affect relatively more
response variables are more likely to be selected into the model. We refer to the
combined penalty in equation (2) as the MAP (MAster Predictor) penalty. We also
refer to the proposed estimator B̂(λ1, λ2) as the remMap (REgularized Multivariate
regression for identifying MAster Predictors) estimator. Note that, the ℓ2 penalty is
a special case (with α = 2) of the more general penalty form:
∑P
p=1 ||Cp ·Bp||α, where
||v||α := (
∑Q
q=1 |vq|
α)
1
α for a vector v ∈ RQ and α > 1. In Turlach et al. (2005), a
penalty with α = ∞ is used to select a common subset of prediction variables when
modeling multivariate responses. In Yuan et al. (2007), a constraint with α = 2
is applied to the loading matrix in a multivariate linear factor regression model for
dimension reduction. In Obozinskiy et al. (2008), the same constraint is applied to
identify the union support set in the multivariate regression. In the case of multiple
regression, a similar penalty corresponding to α = 2 is proposed by Bakin (1999) and
by Yuan and Lin (2006) for the selection of grouped variables, which corresponds to
the blockwise additive penalty in Antoniadis and Fan (2001) for wavelet shrinkage.
Zhao et al. (2006) propose the penalty with a general α > 1. However, none of these
methods takes into account the high dimensionality of response variables and thus
predictors/factors are simultaneously selected for all responses. On the other hand,
by combining the ℓ2 penalty and the ℓ1 penalty together in the MAP penalty, the
remMap model not only selects a subset of predictors, but also limits the influence
of the selected predictors to only some (but not necessarily all) response variables.
Thus, it is more suitable for the cases when both the number of predictors and the
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number of responses are large. Lastly, we also want to point out a difference between
the MAP penalty and the ElasticNet penalty proposed by Zou et al. (2005), which
combines the ℓ1 norm penalty with the squared ℓ2 norm penalty. The ElasticNet
penalty aims to encourage a group selection effect for highly correlated predictors
under the multiple regression setting. However, the squared ℓ2 norm itself does not
induce sparsity and thus is intrinsically different from the ℓ2 norm penalty discussed
above.
In Section 3, we use extensive simulation studies to illustrate the effects of the
MAP penalty. We compare the remMap method with two alternatives: (i) the joint
method which only utilizes the ℓ1 penalty, that is λ2 = 0 in (2); (ii) the sep method
which performs Q separate lasso regressions. We find that, if there exist large hubs
(master predictors), remMap performs much better than joint in terms of identifying
the true model; otherwise, the two methods perform similarly. This suggests that the
“simultaneous” variable selection enhanced by the ℓ2 penalty pays off when there exist
a small subset of “important” predictors, and it costs little when such predictors are
absent. In addition, both remMap and joint methods impose sparsity of the coeffi-
cient matrix as a whole. This helps to borrow information across different regressions
corresponding to different response variables, and thus incorporates the relationships
among response variables into the model. It also amounts to a greater degree of reg-
ularization, which is usually desirable for the high-dimension-low-sample-size setting.
On the other hand, the sep method controls sparsity for each individual regression
separately and thus is subject to high variability and over-fitting. As can be seen by
the simulation studies (Section 3), this type of “joint” modeling greatly improves the
model efficiency. This is also noted by other authors including Turlach et al. (2005),
Lutz and Bu¨hlmann (2006) and Obozinskiy et al. (2008).
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2.2 Model Fitting
In this section, we propose an iterative algorithm for solving the remMap estimator
B̂(λ1, λ2). This is a convex optimization problem when the two tuning parameters
are not both zero, and thus there exists a unique solution. We first describe how to
update one row of B, when all other rows are fixed.
Theorem 1 Given {Bp}p 6=p0 in (2), the solution for minBp0 L(B;λ1, λ2) is given by
B̂p0 = (β̂p0,1, · · · , β̂p0,Q) which satisfies: for 1 ≤ q ≤ Q
(i) If cp0,q = 0, β̂p0,q = X
T
p0
Y˜q/‖Xp0‖
2
2 (OLS), where Y˜q = Yq −
∑
p 6=p0
Xpβpq;
(ii) If cp0,q = 1,
β̂p0,q =

0, if ‖B̂lassop0 ‖2,C = 0;(
1− λ2
‖bBlassop0 ‖2,C ·‖Xp0‖
2
2
)
+
β̂ lassop0,q , otherwise,
(3)
where
||B̂lassop0 ||2,C :=
{
Q∑
q=1
cp0,q(β̂
lasso
p0,q
)2
}1/2
,
and
β̂ lassop0,q =

XTp0Y˜q/‖Xp0‖
2
2, if cp0,q = 0;(
|XTp0Y˜q| − λ1
)
+
sign(XTp0 eYq)
‖Xp0‖
2
2
, if cp0,q = 1.
(4)
The proof of Theorem 1 is given in the supplementary material (Appendix A).
Theorem 1 says that, when estimating the pth0 row of the coefficient matrix B with
all other rows fixed: if there is a pre-specified relationship between the pth0 predictor
and the qth response (i.e., cp0,q = 0), the corresponding coefficient βp0,q is estimated
by the (univariate) ordinary least square solution (OLS) using current responses Y˜q;
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otherwise, we first obtain the lasso solution β̂ lassop0,q by the (univariate) soft shrinkage
of the OLS solution (equation (4)), and then conduct a group shrinkage of the lasso
solution (equation (3)). From Theorem 1, it is easy to see that, when the design
matrix X is orthonormal: XTX = Ip and λ1 = 0, the remMap method amounts to
selecting variables according to the ℓ2 norm of their corresponding OLS estimates.
Theorem 1 naturally leads to an algorithm which updates the rows of B iter-
atively until convergence. In particular, we adopt the active-shooting idea pro-
posed by Peng et al. (2008) and Friedman et al. (2008), which is a modification of
the shooting algorithm proposed by Fu (1998) and also Friedman et al. (2007)
among others. The algorithm proceeds as follows:
1. Initial step: for p = 1, ..., P ; q = 1, ..., Q,
β̂0p,q =
 X
T
p Yq/‖Xp‖
2
2, if cp,q = 0;(
|XTp Yq| − λ1
)
+
sign(XTp Yq)
‖Xp‖22
, if cp,q = 1.
(5)
2. Define the current active-row set Λ = {p : current ||B̂p||2,C 6= 0}.
(2.1) For each p ∈ Λ, update B̂p with all other rows of B fixed at their current
values according to Theorem 1.
(2.2) Repeat (2.1) until convergence is achieved on the current active-row set.
3. For p = 1 to P , update B̂p with all other rows of B fixed at their current values
according to Theorem 1. If no B̂p changes during this process, return the current
B̂ as the final estimate. Otherwise, go back to step 2.
It is clear that the computational cost of the above algorithm is in the order of
O(NPQ).
2.3 Tuning
In this section, we discuss the selection of the tuning parameters (λ1, λ2) by v-fold
cross validation. To perform the v-fold cross validation, we first partition the whole
data set into V non-overlapping subsets, each consisting of approximately 1/V frac-
tion of total samples. Denote the ith subset as D(i) = (Y(i),X(i)), and its comple-
ment as D−(i) = (Y−(i),X−(i)). For a given (λ1, λ2), we obtain the remMap estimate:
B̂(i)(λ1, λ2) = (β̂
(i)
pq ) based on the ith training set D−(i). We then obtain the ordi-
nary least square estimates B̂
(i)
ols(λ1, λ2) = (β̂
(i)
ols,pq) as follows: for 1 ≤ q ≤ Q, define
Sq = {p : 1 ≤ p ≤ P, β̂
(i)
pq 6= 0}. Then set β̂
(i)
ols,pq = 0 if p /∈ Sq; otherwise, define
{β̂
(i)
ols,pq : p ∈ Sq} as the ordinary least square estimates by regressing Y
−(i)
q onto
{X
−(i)
p : p ∈ Sq}. Finally, prediction error is calculated on the test set D
(i):
remMap.cvi(λ1, λ2) := ||Y
(i) −X(i)B̂
(i)
ols(λ1, λ2)||
2
2. (6)
The v-fold cross validation score is then defined as
remMap.cv(λ1, λ2) =
V∑
i=1
remMap.cvi(λ1, λ2). (7)
The reason for using OLS estimates in calculating the prediction error is because
the true model is assumed to be sparse. As noted by Efron et al. (2004), when there
are many noise variables, using shrunken estimates in the cross validation criterion
often results in over fitting. Similar results are observed in our simulation studies: if
in (6) and (7), the shrunken estimates are used, the selected models are all very big
which result in large numbers of false positive findings. In addition, we also try AIC
and GCV for tuning and both criteria result in over fitting as well. These results are
not reported in the next section due to space limitation.
In order to further control the false positive findings, we propose a method called
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cv.vote. The idea is to treat the training data from each cross-validation fold as
a “bootstrap” sample. Then variables being consistently selected by many cross
validation folds should be more likely to appear in the true model than the variables
being selected only by few cross validation folds. Specifically, for 1 ≤ p ≤ P and
1 ≤ q ≤ Q, define
spq(λ1, λ2) =
 1, if
∑V
i=1 I(β̂
(i)
pq (λ1, λ2) 6= 0) > Va;
0, otherwise.
(8)
where Va is a pre-specified integer. We then select edge (p, q) if spq(λ1, λ2) = 1. In
the next section, we use Va = 5 and thus cv.vote amounts to a “majority vote”
procedure. Simulation studies in Section 3 suggest that, cv.vote can effectively
decrease the number of false positive findings while only slightly increase the number
of false negatives.
An alternative tuning method is by a BIC criterion. Compared to v-fold cross
validation, BIC is computationally cheaper. However it requires much more assump-
tions. In particular, the BIC method uses the degrees of freedom of each remMap
model which is difficult to estimate in general. In the supplementary material, we
derive an unbiased estimator for the degrees of freedom of the remMap models when
the predictor matrix X has orthogonal columns (Theorem 2 of Appendix B in the
supplementary materials). In Section 3, we show by extensive simulation studies that,
when the correlations among the predictors are complicated, this estimator tends to
select very small models. For more details see the supplementary material, Appendix
B.
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3 Simulation
In this section, we investigate the performance of the remMap model and compare it
with two alternatives: (i) the joint model with λ2 = 0 in (2); (ii) the sep model
which performs Q separate lasso regressions. For each model, we consider three tuning
strategies, which results in nine methods in total:
1. remMap.cv, joint.cv, sep.cv: The tuning parameters are selected through
10-fold cross validation;
2. remMap.cv.vote, joint.cv.vote, sep.cv.vote: The cv.vote procedure
with Va = 5 is applied to the models resulted from the corresponding ∗.cv
approaches;
3. remMap.bic, joint.bic, sep.bic: The tuning parameters are selected
by a BIC criterion. For remMap.bic and joint.bic, the degrees of freedom
are estimated according to equation (S-6) in Appendix B of the supplementary
material; for sep.bic, the degrees of freedom of each regression is estimated by
the total number of selected predictors (Zou et al. 2007).
We simulate data as follows. Given (N,P,Q), we first generate the predictors
(x1, · · · , xP )
T ∼ NormalP (0,ΣX), where ΣX is the predictor covariance matrix (for
simulations 1 and 2, ΣX(p, p
′) := ρ
|p−p′|
x ). Next, we simulate a P × Q 0-1 adjacency
matrix A, which specifies the topology of the network between predictors and re-
sponses, with A(p, q) = 1 meaning that xp influences yq, or equivalently βpq 6= 0. In
all simulations, we set P = Q and the diagonals of A equal to one, which is viewed
as prior information (thus the diagonals of C are set to zero). This aims to mimic
cis-regulations of DNA copy number alternations on its own expression levels. We
then simulate the P × Q regression coefficient matrix B = (βpq) by setting βpq = 0,
if A(p, q) = 0; and βpq ∼ Uniform([−5,−1] ∪ [1, 5]), if A(p, q) = 1. After that, we
generate the residuals (ǫ1, · · · , ǫQ)
T ∼ NormalQ(0,Σǫ), where Σǫ(q, q
′) = σ2ǫρ
|q−q′|
ǫ .
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The residual variance σ2ǫ is chosen such that the average signal to noise ratio equals
to a pre-specified level s. Finally, the responses (y1, · · · , yQ)
T are generated according
to model (1). Each data set consists of N i.i.d samples of such generated predictors
and responses. For all methods, predictors and responses are standardized to have
(sample) mean zero and standard deviation one before model fitting. Results reported
for each simulation setting are averaged over 25 independent data sets.
For all simulation settings, C = (cpq) is taken to be cpq = 0, if p = q; and
cpq = 1, otherwise. Our primary goal is to identify the trans-edges — the predictor-
response pairs (xp, yq) with A(p, q) = 1 and C(p, q) = 1, i.e., the edges that are not
pre-specified by the indicator matrix C. Thus, in the following, we report the number
of false positive detections of trans-edges (FP) and the number of false negative
detections of trans-edges (FN) for each method. We also examine these methods in
terms of predictor selection. Specifically, a predictor is called a cis-predictor if it
does not have any trans-edges; otherwise it is called a trans-predictor. Moreover,
we say a false positive trans-predictor (FPP) occurs if a cis-predictor is incorrectly
identified as a trans-predictor; we say a false negative trans-predictor (FNP) occurs
if it is the other way around.
Simulation I
We first assess the performances of the nine methods under various combinations of
model parameters. Specifically, we consider: P = Q = 400, 600, 800; s = 0.25, 0.5, 0.75;
ρx = 0, 0.4, 0.8; and ρǫ = 0, 0.4, 0.8. For all settings, the sample size N is fixed at 200.
The networks (adjacency matrices A) are generated with 5 master predictors (hubs),
each influencing 20 ∼ 40 responses; and all other predictors are cis-predictors.
We set the total number of tran-edges to be 132 for all networks. Results on
trans-edge detection are summarized in Figures 1 and 2. From these figures, it is
16
clear that remMap.cv and remMap.cv.vote perform the best in terms of the total
number of false detections (FP+FN), followed by remMap.bic. The three sep meth-
ods result in too many false positives (especially sep.cv). This is expected since
there are in total Q tuning parameters selected separately, and the relations among
responses are not utilized at all. This leads to high variability and over-fitting. The
three joint methods perform reasonably well, though they have considerably larger
number of false negative detections compared to remMap methods. This is because
the joint methods incorporate less information about the relations among the re-
sponses caused by the master predictors. Finally, comparing cv.vote to cv, we can
see that the cv.vote procedure effectively decreases the false positive detections and
only slightly inflates the false negative counts.
As to the impact of different model parameters, signal size s plays an important
role for all methods: the larger the signal size, the better these methods perform
(Figure 1(a)). Dimensionality (P,Q) also shows consistent impacts on these meth-
ods: the larger the dimension, the more false negative detections (Figure 1(b)). With
increasing predictor correlation ρx, both remMAP.bic and joint.bic tend to select
smaller models, and consequently result in less false positives and more false nega-
tives (Figure 2(a)). This is because when the design matrix X is further away from
orthogonality, (S-6) tends to overestimate the degrees of freedom and consequently
smaller models are selected. The residual correlation ρǫ seems to have little impact
on joint and sep, and some (though rather small) impacts on remMap (Figure 2(b)).
Moreover, remMap performs much better than joint and sep on master predictor se-
lection, especially in terms of the number of false positive trans-predictors (results
not shown). This is because the ℓ2 norm penalty is more effective than the ℓ1 norm
penalty in excluding irrelevant predictors.
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Simulation II
In this simulation, we study the performance of these methods on a network without
big hubs. The data are generated similarly as before with P = Q = 600, N = 200,
s = 0.25, ρx = 0.4, and ρǫ = 0. The network consists of 540 cis-predictors, and
60 trans-predictors with 1 ∼ 4 trans-edges. This leads to 151 trans-edges in
total. As can be seen from Table 1, remMap methods and joint methods now perform
very similarly and both are considerably better than the sep methods. Indeed, under
this setting, λ2 is selected (either by cv or bic) to be small in the remMap model,
making it very close to the joint model.
Table 1: Simulation II. Network topology: uniform network with 151 trans-edges
and 60 trans-predictors. P = Q = 600, N = 200; s = 0.25; ρx = 0.4; ρǫ = 0.
Method FP FN TF FPP FNP
remMap.bic 4.72(2.81) 45.88(4.5) 50.6(4.22) 1.36(1.63) 11(1.94)
remMap.cv 18.32(11.45) 40.56(5.35) 58.88(9.01) 6.52(5.07) 9.2(2)
remMap.cv.vote 2.8(2.92) 50.32(5.38) 53.12(3.94) 0.88(1.26) 12.08(1.89)
joint.bic 5.04(2.68) 52.92(3.6) 57.96(4.32) 4.72(2.64) 9.52(1.66)
joint.cv 16.96(10.26) 46.6(5.33) 63.56(7.93) 15.36(8.84) 7.64(2.12)
joint.cv.vote 2.8(2.88) 56.28(5.35) 59.08(4.04) 2.64(2.92) 10.40(2.08)
sep.bic 78.92(8.99) 37.44(3.99) 116.36(9.15) 67.2(8.38) 5.12(1.72)
sep.cv 240.48(29.93) 32.4(3.89) 272.88(30.18) 179.12(18.48) 2.96(1.51)
sep.cv.vote 171.00(20.46) 33.04(3.89) 204.04(20.99) 134.24(14.7) 3.6(1.50)
FP: false positive; FN: false negative; TF: total false; FPP: false positive trans-predictor ;
FNP: false negative trans-predictor. Numbers in the parentheses are standard deviations
Simulation III
In this simulation, we try to mimic the true predictor covariance and network topol-
ogy in the real data discussed in the next section. We observe that, for chromoso-
mal regions on the same chromosome, the corresponding copy numbers are usually
positively correlated, and the magnitude of the correlation decays slowly with ge-
netic distance. On the other hand, if two regions are on different chromosomes, the
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correlation between their copy numbers could be either positive or negative and in
general the magnitude is much smaller than that of the regions on the same chro-
mosome. Thus in this simulation, we first partition the P predictors into 23 distinct
blocks, with the size of the ith block proportional to the number of CNAI (copy num-
ber alteration intervals) on the ith chromosome of the real data (see Section 4 for
the definition of CNAI). Denote the predictors within the ith block as xi1, · · · , xigi,
where gi is the size of the i
th block. We then define the within-block correlation as:
Corr(xij , xil) = ρ
0.5|j−l|
wb for 1 ≤ j, l ≤ gi; and define the between-block correlation as
Corr(xij,, xkl) ≡ ρik for 1 ≤ j ≤ gi, 1 ≤ l ≤ gk and 1 ≤ i 6= k ≤ 23. Here, ρik
is determined in the following way: its sign is randomly generated from {−1, 1}; its
magnitude is randomly generated from {ρbb, ρ
2
bb, · · · , ρ
23
bb}. In this simulation, we set
ρwb = 0.9, ρbb = 0.25 and use P = Q = 600, N = 200, s = 0.5, and ρǫ = 0.4. The
heatmaps of the (sample) correlation matrix of the predictors in the simulated data
and that in the real data are given by Figure S-2 in the supplementary material. The
network is generated with five large hub predictors each having 14 ∼ 26 trans-edges;
five small hub predictors each having 3 ∼ 4 trans-edges; 20 predictors having 1 ∼ 2
trans-edges; and all other predictors being cis-predictors.
The results are summarized in Table 2. Among the nine methods, remMap.cv.vote
performs the best in terms of both edge detectiion and master predictor prediction.
remMAP.bic and joint.bic result in very small models due to the complicated corre-
lation structure among the predictors. While all three cross-validation based methods
have large numbers of false positive findings, the three cv.vote methods have much
reduced false positive counts and only slightly increased false negative counts. These
findings again suggest that cv.vote is an effective procedure in controlling false pos-
itive rates while not sacrificing too much in terms of power.
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Table 2: Simulation III. Network topology: five large hubs and five small hubs
with 151 trans-edges and 30 trans-predictors. P = Q = 600, N = 200; s =
0.5; ρwb = 0.9, ρbb = 0.25; ρǫ = 0.4.
Method FP FN TF FPP FNP
remMap.bic 0(0) 150.24(2.11) 150.24(2.11) 0(0) 29.88(0.33)
remMap.cv 93.48(31.1) 20.4(3.35) 113.88(30.33) 15.12(6.58) 3.88(1.76)
remMap.cv.vote 48.04(17.85) 27.52(3.91) 75.56(17.67) 9.16(4.13) 5.20(1.91)
joint.bic 7.68(2.38) 104.16(3.02) 111.84(3.62) 7(2.18) 10.72(1.31)
joint.cv 107.12(13.14) 39.04(3.56) 146.16(13.61) 66.92(8.88) 1.88(1.2)
joint.cv.vote 63.80(8.98) 47.44(3.90) 111.24(10.63) 41.68(6.29) 2.88(1.30)
sep.bic 104.96(10.63) 38.96(3.48) 143.92(11.76) 64.84(6.29) 1.88(1.17)
sep.cv 105.36(11.51) 37.28(4.31) 142.64(12.26) 70.76(7.52) 1.92(1.08)
sep.cv.vote 84.04(10.47) 41.44(4.31) 125.48(12.37) 57.76 (6.20) 2.4 (1.32)
FP: false positive; FN: false negative; TF: total false; FPP: false positive trans-predictor ;
FNP: false negative trans-predictor. Numbers in the parentheses are standard deviations
4 Real application
In this section, we apply the proposed remMap method to the breast cancer study
mentioned earlier. Our goal is to search for genome regions whose copy number
alterations have significant impacts on RNA expression levels, especially on those of
the unlinked genes, i.e., genes not falling into the same genome region. The findings
resulting from this analysis may help to cast light on the complicated interactions
among DNA copy numbers and RNA expression levels.
4.1 Data preprocessing
The 172 tumor samples were analyzed using cDNA expression microarray and CGH
array experiments as described in Sorlie et al. (2001), Sorlie et al. (2003), Zhao et al. (2004), Kapp et al. (2006),
Bergamaschi et al. (2006), Langerod et al. (2007), and Bergamaschi et al. (2008).
In below, we outline the data preprocessing steps. More details are provided in the
supplementary material (Appendix C).
Each CGH array contains measurements (log2 ratios) on about 17K mapped hu-
man genes. A positive (negative) measurement suggests a possible copy number gain
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(loss). After proper normalization, cghFLasso (Tibshirani and Wang 2008) is used to
estimate the DNA copy numbers based on array outputs. Then, we derive copy num-
ber alteration intervals (CNAIs) — basic CNA units (genome regions) in which genes
tend to be amplified or deleted at the same time within one sample — by employing
the Fixed-Order Clustering (FOC) method (Wang 2004). In the end, for each CNAI
in each sample, we calculate the mean value of the estimated copy numbers of the
genes falling into this CNAI. This results in a 172 (samples) by 384 (CNAIs) numeric
matrix.
Each expression array contains measurements for about 18K mapped human
genes. After global normalization for each array, we also standardize each gene’s mea-
surements across 172 samples to median= 0 and MAD (median absolute deviation)
= 1. Then we focus on a set of 654 breast cancer related genes, which is derived based
on 7 published breast cancer gene lists (Sorlie et al. 2003; van de Vijver et al. 2002;
Chang et al. 2004; Paik et al. 2004; Wang et al. 2005; Sotiriou et al. 2006; Saal et al. 2007).
This results in a 172 (samples) by 654 (genes) numeric matrix.
When the copy number change of one CNAI affects the RNA level of an unlinked
gene, there are two possibilities: (i) the copy number change directly affects the RNA
level of the unlinked gene; (ii) the copy number change first affects the RNA level
of an intermediate gene (either linked or unlinked), and then the RNA level of this
intermediate gene affects that of the unlinked gene. Figure 3 gives an illustration of
these two scenarios. In this study, we are more interested in finding the relationships
of the first type. Therefore, we first characterize the interactions among RNA levels
and then account for these relationships in our model so that we can better infer
direct interactions. For this purpose, we apply the space (Sparse PArtial Correlation
Estimation) method to search for associated RNA pairs through identifying non-
zero partial correlations (Peng et al. 2008). The estimated (concentration) network
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(referred to as Exp.Net.664 hereafter) has in total 664 edges — 664 pairs of genes
whose RNA levels significantly correlate with each other after accounting for the
expression levels of other genes.
Another important factor one needs to consider when studying breast cancer is
the existence of distinct tumor subtypes. Population stratification due to these dis-
tinct subtypes could confound our detection of associations between CNAIs and gene
expressions. Therefore, we introduce a set of subtype indicator variables, which
later on is used as additional predictors in the remMap model. Specifically, follow-
ing Sorlie et al. (2003), we divide the 172 patients into 5 distinct groups based on
their expression patterns. These groups correspond to the same 5 subtypes sug-
gested by Sorlie et al. (2003) — Luminal Subtype A, Luminal Subtype B, ERBB2-
overexpressing Subtype, Basal Subtype and Normal Breast-like Subtype.
4.2 Interactions between CNAIs and RNA expressions
We then apply the remMap method to study the interactions between CNAIs and RNA
transcript levels. For each of the 654 breast cancer genes, we regress its expression
level on three sets of predictors: (i) expression levels of other genes that are connected
to the target gene (the current response variable) in Exp.Net.664 ; (ii) the five subtype
indicator variables derived in the previous section; and (iii) the copy numbers of all
384 CNAIs. We are interested in whether any unlinked CNAIs are selected into this
regression model (i.e., the corresponding regression coefficients are non-zero). This
suggests potential trans-regulations (trans-edges) between the selected CNAIs and
the target gene expression. The coefficients of the linked CNAI of the target gene are
not included in the MAP penalty (this corresponds to cpq = 0, see Section 2 for details).
This is because the DNA copy number changes of one gene often influence its own
expression level, and we are less interested in this kind of cis-regulatory relationships
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(cis-edges) here. Furthermore, based on Exp.Net.664, no penalties are imposed on
the expression levels of connected genes either. In another word, we view the cis-
regulations between CNAIs and their linked expression levels, as well as the inferred
RNA interaction network as “prior knowledge” in our study.
Note that, different response variables (gene expressions) now have different sets of
predictors, as their neighborhoods in Exp.Net.664 are different. However, the remMap
model can still be fitted with a slight modification. The idea is to treat all CNAI
(384 in total), all gene expressions (654 in total), as well as five subtype indicators
as nominal predictors. Then, for each target gene, we force the coefficients of those
gene expressions that do not link to it in Exp.Net.664 to be zero. We can easily
achieve this by setting those coefficients to zero without updating them throughout
the iterative fitting procedure.
We select tuning parameters (λ1, λ2) in the remMap model through a 10-fold cross
validation as described in Section 2.3. The optimal (λ1, λ2) corresponding to the
smallest CV score from a grid search is (355.1, 266.7). The resulting model con-
tains 56 trans-regulations in total. In order to further control false positive findings,
we apply the cv.vote procedure with Va = 5, and filter away 13 out of these 56
trans-edges which have not been consistently selected across different CV folds.
The remaining 43 trans-edges correspond to three contiguous CNAIs on chromo-
some 17 and 31 distinct (unlinked) RNAs. Figure 4 illustrates the topology of the
estimated regulatory relationships. The detailed annotations of the three CNAIs and
31 RNAs are provided in Table 3 and Table 4. Moreover, the Pearson-correlations
between the DNA copy numbers of CNAIs and the expression levels of the regu-
lated genes/clones (including both cis-regulation and trans-regulation) across
the 172 samples are reported in Table 4. As expected, all the cis-regulations have
much higher correlations than the potential trans-regulations. In addition, none of
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Table 3: Genome locations of the three CNAIs having (estimated) trans-regulations.
Index Cytoband Begin1 End 1 # of clones2 # of Trans-Reg3
1 17q12-17q12 34811630 34811630 1 12
2 17q12-17q12 34944071 35154416 9 30
3 17q21.1-17q21.2 35493689 35699243 7 1
1. Nucleotide position (bp).
2. Number of genes/clones on the array falling into the CNAI.
3. Number of unlinked genes whose expressions are estimated to be regulated by the CNAI.
the subtype indicator variables is selected into the final model, which implies that
the detected associations between copy numbers of CNAIs and gene expressions are
unlikely due to the stratification of the five tumor subtypes.
The three CNAIs being identified as trans-regulators sit closely on chromosome
17, spanning from 34811630bp to 35699243bp and falling into cytoband 17q12-q21.2.
This region (referred to as CNAI-17q12 hereafter) contains 24 known genes, including
the famous breast cancer oncogene ERBB2, and the growth factor receptor-bound
protein 7 (GRB7). The over expression of GRB7 plays pivotal roles in activating
signal transduction and promoting tumor growth in breast cancer cells with chro-
mosome 17q11-21 amplification (Bai and Louh 2008). In this study, CNAI-17q12 is
highly amplified (normalized log2 ratio> 5) in 33 (19%) out of the 172 tumor samples.
Among the 654 genes/clones considered in the above analysis, 8 clones (correspond-
ing to six genes including ERBB2, GRB7, and MED24) fall into this region. The
expressions of these 8 clones are all up-regulated by the amplification of CNAI-17q12
(see Table 4 for more details), which is consistent with results reported in the liter-
ature (Kao and Pollack 2006). More importantly, as suggested by the result of the
remMap model, the amplification of CNAI-17q12 also influences the expression levels of
31 unlinked genes/clones. This implies that CNAI-17q12 may harbor transcriptional
factors whose activities closely relate to breast cancer. Indeed, there are 4 transcrip-
tion factors (NEUROD2, IKZF3, THRA, NR1D1) and 2 transcriptional co-activators
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(MED1, MED24) in CNAI-17q12. It is possible that the amplification of CNAI-17q12
results in the over expression of one or more transcription factors/co-activators in this
region, which then influence the expressions of the unlinked 31 genes/clones. In ad-
dition, some of the 31 genes/clones have been reported to have functions directly
related to cancer and may serve as potential drug targets (see Appendix C.6 of the
supplementary material for more details). In the end, we want to point out that, be-
sides RNA interactions and subtype stratification, there could be other unaccounted
confounding factors. Therefore, caution must be applied when one tries to interpret
these results.
5 Discussion
In this paper, we propose the remMap method for fitting multivariate regression mod-
els under the large P,Q setting. We focus on model selection, i.e., the identification of
relevant predictors for each response variable. remMap is motivated by the rising needs
to investigate the regulatory relationships between different biological molecules based
on multiple types of high dimensional omics data. Such genetic regulatory networks
are usually intrinsically sparse and harbor hub structures. Identifying the hub regula-
tors (master regulators) is of particular interest, as they play crucial roles in shaping
network functionality. To tackle these challenges, remMap utilizes a MAP penalty, which
consists of an ℓ1 norm part for controlling the overall sparsity of the network, and
an ℓ2 norm part for further imposing a row-sparsity of the coefficient matrix, which
facilitates the detection of master predictors (regulators). This combined regulariza-
tion takes into account both model interpretability and computational tractability.
Since the MAP penalty is imposed on the coefficient matrix as a whole, it helps to
borrow information across different regressions and thus incorporates the relation-
ships among response variables into the model. As illustrated in Section 3, this type
25
of “joint” modeling greatly improves model efficiency. Also, the combined ℓ1 and ℓ2
norm penalty further enhances the performance on both edge detection and master
predictor identification.
We also propose a cv.vote procedure to make better use of the cross validation
results. The idea is to treat the training data from each cross-validation fold as a
“bootstrap” sample and identify the variables consistently selected in the majority
of the cross-validation folds. As suggested by the simulation study, this procedure is
very effective in decreasing the number of false positives while only slightly increases
the number of false negatives. Moreover, cv.vote can be applied to a broad range of
model selection problems when cross validation is employed.
In the real application, we apply the remMap method on a breast cancer data set.
Our goal is to investigate the influences of DNA copy number alterations on RNA
transcript levels based on 172 breast cancer tumor samples. The resulting model sug-
gests the existence of a trans-hub region on cytoband 17q12-q21, whose amplification
influences RNA levels of 31 unlinked genes. Cytoband 17q12-q21 is a well known
hot region for breast cancer, which harbors the oncogene ERBB2. The above results
suggest that this region may also harbor important transcriptional factors. While
our findings are intriguing, clearly additional investigation is warranted. One way to
verify the above conjecture is through a sequence analysis to search for common mo-
tifs in the upstream regions of the 31 RNA transcripts, which remains as our future
work.
Besides the above application, the remMap model can be applied to investigate the
regulatory relationships between other types of biological molecules. For example,
it is of great interest to understand the influence of single nucleotide polymorphism
(SNP) on RNA transcript levels, as well as the influence of RNA transcript levels
on protein expression levels. Such investigation will improve our understanding of
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related biological systems as well as disease pathology. In addition, we can utilize
the remMap idea to other models. For example, when selecting a group of variables in
a multiple regression model, we can impose both the ℓ2 penalty (that is, the group
lasso penalty), as well as an ℓ1 penalty to encourage within group sparsity. Similarly,
the remMap idea can also be applied to vector autoregressive models and generalize
linear models.
R package remMap is public available through CRAN (http : //cran.r−project.org/).
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Table 4: RNAs1 being influenced by the amplifications of the three CNAIs in Table 3.
Clone ID Gene symbol Cytoband Correlation
753692 ABLIM1 10q25 0.199
896962 ACADS 12q22-qter -0.22
753400 ACTL6A 3q26.33 0.155
472185 ADAMTS1 21q21.2 0.214
210687 AGTR1 3q21-q25 -0.182
856519 ALDH3A2 17p11.2 -0.244
270535 BM466581 19 0.03
238907 CABC1 1q42.13 -0.174
773301 CDH3 16q22.1 0.118
505576 CORIN 4p13-p12 0.196
223350 CP 3q23-q25 0.184
810463 DHRS7B 17p12 -0.151
50582 FLJ25076 5p15.31 0.086
669443 HSF2 6q22.31 0.207
743220 JMJD4 1q42.13 -0.19
43977 KIAA0182 16q24.1 0.259
810891 LAMA5 20q13.2-q13.3 0.269
247230 MARVELD2 5q13.2 -0.214
812088 NLN 5q12.3 0.093
257197 NRBF2 10q21.2 0.275
782449 PCBP2 12q13.12-q13.13 -0.079
796398 PEG3 19q13.4 0.169
293950 PIP5K1A 1q22-q24 -0.242
128302 PTMS 12p13 -0.248
146123 PTPRK 6q22.2-q22.3 0.218
811066 RNF41 12q13.2 -0.247
773344 SLC16A2 Xq13.2 0.24
1031045 SLC4A3 2q36 0.179
141972 STT3A 11q23.3 0.182
454083 TMPO 12q22 0.175
825451 USO1 4q21.1 0.204
68400 BM455010 17 0.748
756253,365147 ERBB2 17q11.2-q12—17q21.1 0.589
510318,236059 GRB7 17q12 0.675
245198 MED24 17q21.1 0.367
825577 STARD3 17q11-q12 0.664
7827562 TBPL1 6q22.1-q22.3 0.658
1. The first part of the table lists the inferred trans-regulated genes. The second
part of the table lists cis-regulated genes.
2. This cDNA sequence probe is annotated with TBPL1, but actually
maps to one of the 17q21.2 genes.
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(a) Impact of signal size s. P = Q = 600, N = 200; ρx = 0.4; ρε = 0; the total number of
trans-edges is 132.
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(b) Impact of predictor and response dimensionality P (Q = P ). N = 200; s = 0.25; ρx = 0.4;
ρε = 0; the total number of trans-edges is 132.
Figure 1: Impact of signal size and dimensionality. Heights of solid bars represent numbers
of false positive detections of trans-edges (FP); heights of shaded bars represent numbers
of false negative detections of trans-edges (FN). All bars are truncated at height=132.
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(a) Impact of predictor correlation ρx. P = Q = 600, N = 200; s = 0.25; ρε = 0; the total number
of trans-edges is 132.
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(b) Impact of residual correlation ρε. P = Q = 600, N = 200; s = 0.25; ρx = 0.4; the total
number of trans-edges is 132.
Figure 2: Impact of correlations. Heights of solid bars represent numbers of false positive
detections of trans-edges (FP); heights of shaded bars represent numbers of false negative
detections of trans-edges (FN). All bars are truncated at height=132.
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Figure 3: (a) Direct interaction between CNAI A and the expression of gene B;
(b) indirect interaction between CNAI A and the expression of Gene B through one
intermediate gene.
Figure 4: Network of the estimated regulatory relationships between the copy numbers
of the 384 CNAIs and the expressions of the 654 breast cancer related genes. Each
blue node stands for one CNAI, and each green node stands for one gene. Red edges
represent inferred trans-regulations (43 in total). Grey edges represent cis-regulations.
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Supplementary Material
Appendix A: Proof of Theorem 1
Define
L(β; Y,X) =
1
2
Q∑
q=1
(yq − xβq)
2 + λ1
Q∑
q=1
|βq|+ λ2
√√√√ Q∑
q=1
β2q .
It is obvious that, in order to prove Theorem 1, we only need to show that, the
solution of minβ L(β; Y,X), is given by (for q = 1, · · · , Q)
β̂q =

0, if ||β̂ lasso||2 = 0;
β̂ lassoq
(
1− λ2
||bβlasso||2x2
)
+
, otherwise,
where
β̂ lassoq =
(
1−
λ1
|xyq|
)
+
xyq
x2
. (S-1)
In the following, for function L, view {βq′ : q
′ 6= q} as fixed. With a slight abuse of
notation, write L = L(βq). Then when βq ≥ 0, we have
dL
dβq
= −xyq + (x
2 +
λ2
||β||2
)βq + λ1.
Thus, dL
dβq
> 0 if and only if βq > β˜q
+
, where
β˜q
+
:=
xyq
x2 + λ2
||β||2
(1−
λ1
xyq
).
1
Denote the minima of L(βq)|βq≥0 by β
+
q,min. Then, when β˜q
+
> 0, β+q,min = β˜q
+
.
On the other hand, when β˜q
+
≤ 0, β+q,min = 0. Note that β˜q
+
> 0 if and only if
xyq(1−
λ1
xyq
) > 0. Thus we have
β+q,min =
 β˜
+
q , if xyq(1−
λ1
xyq
) > 0;
0, if xyq(1−
λ1
xyq
) ≤ 0.
Similarly, denote the minima of L(βq)|βq≤0 by β
−
q,min, and define
β˜q
−
:=
xyq
x2 + λ2
||β||2
(1 +
λ1
xyq
).
Then we have
β−q,min =
 β˜
−
q , if xyq(1 +
λ1
xyq
) < 0;
0, if xyq(1 +
λ1
xyq
) ≥ 0.
Denote the minima of L(βq) as β̂q (with a slight abuse of notation). From the above, it
is obvious that, if xyq > 0, then β̂q ≥ 0. Thus β̂q = max(β˜
+
q , 0) =
xyq
x2+
λ2
||β||2
(1− λ1
xyq
)+ =
xyq
x2+
λ2
||β||2
(1− λ1
|xyq|
)+. Similarly, if xyq ≤ 0, then β̂q ≤ 0, and it has the same expression as
above. Denote the minima of L(β)|||β||2>0 (now viewed as a function of (β1, · · · , βQ))
as β̂min = (β̂1,min, · · · , β̂Q,min). We have shown above that, if such a minima exists, it
satisfies (for q = 1, · · · , Q)
β̂q,min =
xyq
x2 + λ2
||bβmin||2
(
1−
λ1
|xyq|
)
+
= β̂ lassoq
x2
x2 + λ2
||bβmin||2
, (S-2)
where β̂ lassoq is defined by equation (S-1). Thus
||β̂min||2 = ||β̂
lasso||2
x2
x2 + λ2
||bβmin||2
.
2
By solving the above equation, we obtain
||β̂min||2 = ||β̂
lasso||2 −
λ2
x2
.
By plugging the expression on the right hand side into (S-2), we achieve
β̂q,min = β̂
lasso
q
(
1−
λ2
||β̂ lasso||2x2
)
.
Denote the minima of L(β) by β̂ = (β̂1, · · · , β̂Q). From the above, we also know that
if ||β̂ lasso||2 −
λ2
x2
> 0, L(β) achieves its minimum on ||β||2 > 0, which is β̂ = β̂min.
Otherwise, L(β) achieves its minimum at zero. Since ||β̂ lasso||2−
λ2
x2
> 0 if and only if
1− λ2
||bβlasso||2x2
> 0, we have proved the theorem.
Appendix B: BIC criterion for tuning
In this section, we describe the BIC criterion for selecting (λ1, λ2). We also derive an
unbiased estimator of the degrees of freedom of the remMap estimator under orthogonal
design.
In model (1), by assuming ǫq ∼ Normal(0, σ
2
q,ǫ), the BIC criterion for the q
th
regression can be defined as
BICq(β̂1q, · · · , β̂Pq; dfq) = N × log(RSSq) + logN × dfq, (S-3)
where RSSq :=
∑N
n=1(y
n
q − ŷ
n
q )
2 with ŷnq =
∑P
p=1 x
n
p β̂pq; and dfq is the degrees of
freedom which is defined as
dfq = dfq(β̂1q, · · · , β̂Pq) :=
N∑
n=1
Cov(ŷnq , y
n
q )/σ
2
q,ǫ, (S-4)
3
where σ2q,ǫ is the variance of ǫq.
For a given pair of (λ1, λ2), We then define the (overall) BIC criterion at (λ1, λ2):
BIC(λ1, λ2) = N ×
Q∑
q=1
log(RSSq(λ1, λ2)) + logN ×
Q∑
q=1
dfq(λ1, λ2). (S-5)
Efron et al. (2004) derive an explicit formula for the degrees of freedom of lars un-
der orthogonal design. Similar strategy are also used by Yuan and Lin (2006) among
others. In the following theorem, we follow the same idea and derive an unbiased
estimator of dfq for remMap when the columns of X are orthogonal to each other.
Theorem 2 Suppose XTp Xp′ = 0 for all 1 ≤ p 6= p
′ ≤ P . Then for given (λ1, λ2),
d̂f q(λ1, λ2) :=
P∑
p=1
cpq × I
(
||B̂lassop ||2,C >
λ2
||Xp||
2
2
)
× I
(
|β̂olspq | >
λ1
||Xp||
2
2
)
×
(
1−
λ2
||Xp||22
||B̂lassop ||
2
2,C − (β̂
lasso
pq )
2
||B̂lassop ||
3
2,C
)
+
P∑
p=1
(1− cp,q) (S-6)
is an unbiased estimator of the degrees of freedom dfq(λ1, λ2) (defined in equation
(S-4)) of the remMap estimator B̂ = B̂(λ1, λ2) = (β̂pq(λ1, λ2)). Here, under the
orthogonal design, β̂pq, β̂
lasso
pq are given by Theorem 1 with Y˜q = Yq (q = 1, · · · , Q),
and β̂olspq :=
XTp Yq
||Xp||22
.
Before proving Theorem 2, we first explain definition (S-4) – the degrees of free-
dom. Consider the qth regression in model (1). Suppose that {ŷnq }
N
n=1 are the fitted
values by a certain fitting procedure based on the current observations {ynq : n =
1, · · · , N ; q = 1, · · · , Q}. Let µnq :=
∑P
p=1 x
n
pβpq. Then for a fixed design matrix
X = (xnp ), the expected re-scaled prediction error of {ŷ
n
q }
N
n=1 in predicting a future
4
set of new observations {y˜nq }
N
n=1 from the q
th regression of model (1) is:
PEq =
N∑
n=1
E((ŷnq − y˜
n
q )
2)/σ2q,ǫ =
N∑
n=1
E((ŷnq − µ
n
q )
2)/σ2q,ǫ +N.
Note that
(ŷnq − y
n
q )
2 = (ŷnq − µ
n
q )
2 + (ynq − µ
n
q )
2 − 2(ŷnq − µ
n
q )(y
n
q − µ
n
q ).
Therefore,
PEq =
N∑
n=1
E((ŷnq − y
n
q )
2)/σ2q,ǫ + 2
N∑
n=1
Cov(ŷnq , y
n
q )/σ
2
q,ǫ.
Denote RSSq =
∑N
n=1(ŷ
n
q − y
n
q )
2. Then an un-biased estimator of PEq is
RSSq/σ
2
q,ǫ + 2
N∑
n=1
Cov(ŷnq , y
n
q )/σ
2
q,ǫ.
Therefore, a natural definition of the degrees of freedom for the procedure resulting
the fitted values {ŷnq }
N
n=1 is as given in equation (S-4). Note that, this is the definition
used in Mallow’s Cp criterion.
Proof of Theorem 2: By applying Stein’s identity to the Normal distribution, we
have: if Z ∼ N(µ, σ2), and a function g such that E(|g′(Z)|) <∞, then
Cov(g(Z), Z)/σ2 = E(g′(Z)).
Therefore, under the normality assumption on the residuals {ǫq}
Q
q=1 in model (1),
definition (S-4) becomes
dfq =
N∑
n=1
E
(
∂ŷnq
∂ynq
)
, q = 1, · · · , Q.
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Thus an obvious unbiased estimator of dfq is d̂f q =
∑N
n=1
∂bynq
∂ynq
. In the following,
we derive d̂f q for the proposed remMap estimator under the orthogonal design. Let
β̂q = (β̂1q, · · · , β̂Pq) be a one by P row vector; let X = (x
n
p ) be the N by P design
matrix which is orthonormal; let Yq = (y
1
1, · · · , y
N
q )
T and Ŷq = (ŷ
1
q , · · · , ŷ
N
q )
T = Xβ̂q
be N by one column vectors. Then
d̂f q = tr
(
∂Ŷq
∂Yq
)
= tr
(
X
∂β̂q
∂Yq
)
= tr
(
X
∂β̂q
∂β̂q,ols
∂β̂q,ols
∂Yq
)
,
where β̂q,ols = (β̂
ols
1q , · · · , β̂
ols
Pq)
T and the last equality is due to the chain rule. Since
under the orthogonal design, β̂olspq = X
T
p Yq/||Xp||
2
2, where Xp = (x
1
p, · · · , x
N
p )
T , thus
∂ bβq,ols
∂Yq
= DXT , where D is a P by P diagonal matrix with the pth diagonal entry
being 1/||Xp||
2
2. Therefore
d̂f q = tr
(
X
∂β̂q
∂β̂q,ols
DXT
)
= tr
(
DXTX
∂β̂q
∂β̂q,ols
)
= tr
(
∂β̂q
∂β̂q,ols
)
=
P∑
p=1
∂β̂pq
∂β̂olspq
,
where the second to last equality is by XTX = D−1 which is due to the orthogonality
of X. By the chain rule
∂β̂pq
∂β̂olspq
=
∂β̂pq
∂β̂ lassopq
∂β̂ lassopq
∂β̂olspq
.
By Theorem 1, under the orthogonal design,
∂β̂pq
∂β̂ lassopq
= I
(
||B̂lassop ||2,C >
λ2
||Xp||22
)
×
[
1−
λ2
||Xp||22
||B̂lassop ||
2
2,C − (β̂
lasso
pq )
2
||B̂lassop ||
3
2,C
]
,
and
∂β̂ lassopq
∂β̂olspq
=
 1, if cp,q = 0;I(|β̂olspq | > λ1||Xp||22) , if cp,q = 1.
Note that when cp,q = 0, β̂pq = β̂
ols
pq , thus
∂ bβpq
∂ bβolspq
= 1. It is then easy to show that d̂f q
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is as given in equation (S-6).
Note that, when the ℓ2 penalty parameter λ2 is 0, the model becomes q separate
lasso regressions with the same penalty parameter λ1 and the degrees of freedom
estimation in equation (S-6) is simply the total number of non-zero coefficients in
the model (under orthogonal design). When λ2 is nonzero, the degrees of freedom of
remMap estimator should be smaller than the number of non-zero coefficients due to
the additional shrinkage induced by the ℓ2 norm part of the MAP penalty (equation
(3)). This is reflected by equation (S-6).
Appendix C: Data Preprocessing
C.1 Preprocessing for array CGH data
Each array output (log2 ratios) is first standardized to have median= 0 and smoothed
by cghFLasso (Tibshirani and Wang 2008) for defining gained/lost regions on the
genome. The noise level of each array is then calculated based on the measurements
from the estimated normal regions (i.e., regions with estimated copy numbers equal
to 2). After that, each smoothed array is normalized according to its own noise level.
We define copy number alteration intervals (CNAIs) by using the Fixed-Order
Clustering (FOC) method (Wang 2004). FOC first builds a hierarchical clustering
tree along the genome based on all arrays, and then cuts the tree at an appropriate
height such that genes with similar copy numbers fall into the same CNAI. FOC
is a generalization of the CLAC (CLuster Along Chromosome) method proposed by
Wang et al. (2005). It differs in two ways from the standard agglomerative clustering.
First, the order of the leaves in the tree is fixed, which represents the genome order
of the genes/clones in the array. So, only adjacent clusters are joined together when
the tree is generated by a bottom-up approach. Second, the similarity between two
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clusters no longer refers to the spatial distance but to the similarity of the array
measurements (log2 ratio) between the two clusters. By using FOC, the whole genome
is divided into 384 non-overlapping CNAIs based on all 172 CGH arrays. This is
illustrated in Figure S-1. In addition, the heatmap of the (sample) correlations of the
CNAIs is given in Figure S-2.
C.2 Selection of breast cancer related genes
We combine seven published breast cancer gene lists: the intrinsic gene set (Sorlie et al. 2003),
the Amsterdam 70 gene (van de Vijver et al. 2002), the wound response gene set
(Chang et al. 2004), the 76 genes for the metastasis signature (Wang et al. 2005), the
gene list for calculating the recurrence score (Paik et al. 2004), the gene list of the Ge-
nomic Grade Index (GGI) (Sotiriou et al. 2006), and the PTEN gene set (Saal et al. 2007).
Among this union set of breast cancer related genes, 967 overlap with the genes in the
current expression data set. We further filter away genes with missing measurements
in more than 20% of the samples, and 654 genes are left. Among these 654 selected
genes, 449 are from the intrinsic gene set (Sorlie et al. 2003), which are used to derive
breast cancer subtype labels in Appendix C.4.
C.3 Interactions among RNA expressions
We apply the space (Sparse PArtial Correlation Estimation) method (Peng et al. 2008)
to infer the interactions among RNA levels through identifying non-zero partial cor-
relations. space assumes the overall sparsity of the partial correlation matrix and
employs sparse regression techniques for model fitting. As indicated by many exper-
iments that genetic-regulatory networks have a power-law type degree distribution
with a power parameter between 2 and 3 (Newman 2003), the tuning parameter in
space is chosen such that the resulting network has an estimated power parameter
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around 2 (see Figure S-3(b) for the corresponding degree distribution). The resulting
(concentration) network has 664 edges in total, whose topology is illustrated in Fig-
ure S-3(a). In this network, there are 7 nodes having at least 10 edges. These hub
genes include PLK1, PTTG1, AURKA, ESR1, and GATA3. PLK1 has important
functions in maintaining genome stability via its role in mitosis. Its over expression
is associated with preinvasive in situ carcinomas of the breast (Rizki et al. 2007).
PTTG1 is observed to be a proliferation marker in invasive ductal breast carcino-
mas (Talvinen et al. 2008). AURKA encodes a cell cycle-regulated kinase and is
a potential metastasis promoting gene for breast cancer (Thomassen et al. 2008).
ESR1 encodes an estrogen receptor, and is a well known key player in breast cancer.
Moreover, it had been reported that GATA3 expression has a strong association with
estrogen receptor in breast cancer (Voduc et al. 2008). Detailed annotation of these
and other hub genes are listed in Table S-1. We refer to this network as Exp.Net.664,
and use it to account for RNA interactions when investigating the regulations between
CNAIs and RNA levels.
Table S-1: Annotations for hub genes (degrees greater than 10) in the inferred RNA
interaction network Exp.Net.664.
CloneID Gene Name Symbol ID Cytoband
744047 Polo-like kinase 1 (Drosophila) PLK1 5347 16p12.1
781089 Pituitary tumor-transforming 1 PTTG1 9232 5q35.1
129865 Aurora kinase A AURKA 6790 20q13.2-q13.3
214068 GATA binding protein 3 GATA3 2625 10p15
950690 Cyclin A2 CCNA2 890 4q25-q31
120881 RAB31, member RAS oncogene family RAB31 11031 18p11.3
725321 Estrogen receptor 1 ESR1 2099 6q25.1
C.4 Breast Cancer Subtypes
Population stratification due to distinct subtypes could confound our detection of
associations between CNAIs and gene expressions. For example, if the copy number
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of CNAI A and expression level of gene B are both higher in one subtype than in
the other subtypes, we could observe a strong correlation between CNAI A and gene
expression B across the whole population, even when the correlation within each sub-
type is rather weak. To account for this potential confounding factor, we introduce
a set of subtype indicator variables, which is used as additional predictors in the
remMap model. Specifically, we derive subtype labels based on expression patterns by
following the work of Sorlie et al. (2003). We first normalize the expression levels of
each intrinsic gene (449 in total) across the 172 samples to have mean zero and MAD
one. Then we use kmeans clustering to divide the patients into five distinct groups,
which correspond to the five subtypes suggested by Sorlie et al. (2003) — Luminal
Subtype A, Luminal Subtype B, ERBB2-overexpressing Subtype, Basal Subtype and
Normal Breast-like Subtype. Figure S-4 illustrates the expression patterns of these
five subtypes across the 172 samples. We then define five dummy variables to repre-
sent the subtype information for each tumor sample, and include them as predictors
when fitting the remMap model.
C.5 Comments on the results of the remMap analysis.
remMap analysis suggests that the amplification of a trans-hub region on chromosome
17 influences the RNA expression levels of 31 distinct (unlinked) genes. Some of
the 31 genes/clones have been reported to have functions directly related to can-
cer and may serve as potential drug targets. For example, AGTR1 is a receptor
whose genetic polymorphisms have been reported to associate with breast cancer
risk and is possibly druggable (Koh et al. 2005). CDH3 encodes a cell-cell adhe-
sion glycoprotein and is deemed as a candidate of tumor suppressor gene, as dis-
turbance of intracellular adhesion is important for invasion and metastasis of tumor
cells (Kremmidiotis et al. 1998). PEG3 is a mediator between p53 and Bax in DNA
10
damage-induced neuronal death (Johnson et al. 2002) and may function as a tumor
suppressor gene (Dowdy et al. 2005). In a word, these 31 genes may play functional
roles in the pathogenesis of breast cancer and may serve as additional targets for
therapy.
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Figure S-1: Hierarchical tree constructed by FOC. Each leaf represents one gene/clone
on the array. The order of the leaves represents the order of genes on the genome.
The 23 Chromosomes are illustrated with different colors. Cutting the tree at 0.04
(horizonal red line) separates the genome into 384 intervals. This cutoff point is
chosen such that no interval contains genes from different chromosomes.
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XFigure S-2: Heatmaps of the sample correlations among predictors. Top panel: sim-
ulated data; Bottom panel: real data
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(a) Exp.Net.664 : Inferred network for the 654 breast cancer related
genes (based on their expression levels) by space. Nodes with
degrees greater than ten are drawn in blue.
(b) Degree distribution of network
Exp.Net.664.
Figure S-3: Inferred RNA interaction network.
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Figure S-4: Heatmap showing the expressions of the 449 intrinsic genes in the 172
breast cancer tumor samples. Each column represents one sample and each row
represents one gene. The 172 samples are divided into 5 clusters (subtypes). From
the left to the right, the 5 subtypes are: Luminal Subtype A, Luminal Subtype B,
ERBB2-overexpressing subtype, Basal Subtype and Normal Breast-like Subtype.
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